Cargando…
Suppression of bone remodeling associated with long-term bisphosphonate treatment is mediated by microRNA-30a-5p
Oral bisphosphonates (BPs) are a first-line treatment for osteoporosis. It is becoming a hot topic to identify new indicators for the early prediction of therapeutic effects and adverse reactions during the long-term use of BPs. To determine whether microRNA (miRNA) expression is modulated by long-t...
Autores principales: | Li, Xia, Xu, Ruisheng, Ye, Jun-Xing, Yuan, Feng-Lai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161941/ https://www.ncbi.nlm.nih.gov/pubmed/35412438 http://dx.doi.org/10.1080/21655979.2022.2060584 |
Ejemplares similares
-
The role of microRNAs in bone remodeling
por: Jing, Dian, et al.
Publicado: (2015) -
The microRNA in ventricular remodeling: the miR-30 family
por: Zhang, Xiaonan, et al.
Publicado: (2019) -
microRNA‐Mediated Regulation of Bone Remodeling: A Brief Review
por: Liu, Jin, et al.
Publicado: (2019) -
MicroRNA biogenesis and regulation of bone remodeling
por: Kapinas, Kristina, et al.
Publicado: (2011) -
Long-term use of bisphosphonates in osteoporosis
por: Sadat-Ali, Mir, et al.
Publicado: (2017)